References
- Cohen S. Motor disorders of the esophagus. N Engl J Med 1979; 301: 184–92
- Cohen S. The gastrointestinal manifestations of scleroderma: Pathogenesis and management. Gastroenterology 1980; 79: 155–66
- Asboe-Hansen G. Experimental search for connective-tissue active drugs. J Dermatol 1974; 1: 105–16
- Asboe-Hansen G. Treatment of generalized scleroderma with inhibitors of collagen synthesis. Int J Dermatol 1982; 21: 159–61
- Baum J. The use of penicillamine in the treatment of rheumatoid arthritis and scleroderma. Scand J Rheumatol 1979; 28((Suppl))65–70
- Rodnan G. P. Progressive systemic sclerosis and penicillamine. J Rheumatol 1981; 8((Suppl 7))116–20
- Jayson M. I., Lovell C., Black C. M., Wilson R. S. Penicillamine therapy in systemic sclerosis. Proc R Soc Med 1977; 70: 82–7
- Steen V. D., Medsger T. A., Rodnan G. P. D-Penicillamine therapy in progressive systemic sclerosis. Ann Intern Med 1982; 97: 652–9
- Weihrauch T. R., Korting G. W. Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease. Br J Dermatol 1982; 107: 325–32
- Kukovetz W. R., Beubler E., Kreuzig F., Moritz A. J., Nirnberger G., Werner-Breitenecker L. Bioavailability and pharmacokinetics of D-penicillamine. J Rheumatol 1983; 10: 90–4
- Ammitzbøll T., Hendel L., Kreuzig F., Asboe-Hansen G. Small intestinal absorption of D-penicillamine in relation to gastrointestinal involvement of generalized scleroderma. Scand J Rheumatol 1987; 16: 121–6
- Ammitzbøll T., Asboe-Hansen G. Collagen metabolites in the urine in patients with scleroderma. Ugeskr Laeger 1984; 146: 1622–5
- Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria subcommittee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
- Hendel L., Ammitzbøll T., Kreuzig F., Asboe-Hansen G., Worning H. Bioavailability of D-penicillamine in a patient with gastrointestinal progressive sclerosis. Scand J Rheumatol 1986; 15: 91–4
- Aggestrup S., Sørensen A., Carstensen H. E., Sørensen H. R. Computerized 12-hour simultaneous ECG, pressure- and pH-probe investigation of the esophagus. Method and reference values in healthy individuals. Scand J Clin Lab Invest 1981; 41: 749–56
- Blumenkrantz N. Automated triple assay for proline, hydroxyproline and hydroxylysine on one single sample. Clin Biochem 1980; 13: 177–83
- Blumenkranz N., Asboe-Hansen G. High molecular collagen peptide fraction in urine indicates disease activity in generalized scleroderma. Acta Derm Venereol 1976; 56: 415–21
- Blumenkrantz N., Asboe-Hansen G. Variation of urinary acid glycosaminoglycan and collagen metabolite excretion with disease activity in generalized scleroderma. Acta Derm Venereol 1980; 60: 39–43
- Stentoft P., Hendel L., Aggestrup S. Esophageal manometry and pH-probe monitoring in the evaluation of esophageal reflux in patients with progressive systemic sclerosis. Scand J Gastroenterol 1987; 22: 499–504
- Jonckheere A. R. A distribution-free k-sample test against ordered alternatives. Biometrika 1954; 41: 133–45
- Ammitzbøll T., Møller R., Hendel L., Asboe-Hansen G. Urinary excretion and skin concentration of collagen specific aminoacids in relation to D-penicillamine absorption and bioavailability. Proceedings of the 24th Scandinavian Dermatology Congress 1986; 96
- Treacy W. I., Baggenstoss A. H., Slocumb C. H., Code C. F. Scleroderma of the esophagus. Ann Intern Med 1963; 59: 351–6
- D'Angelo W. A., Fries J. F., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma). Am J Med 1969; 46: 428–40
- Robertson D., Aldersley M., Shepherd H., Smith C. L. Patterns of acid reflux in complicated oesophagitis. Gut 1987; 28: 1484–8
- Hendel L., Aggestrup S., Stentoft P. Long-term ranitidine in progressive systemic sclerosis (scleroderma) with gastroesophageal reflux. Scand J Gastroenterol 1986; 21: 797–805